GENESIS Pharma Broadens Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics Across Nordic Markets
GENESIS Pharma, one of the leading regional biopharma companies focused on the commercialisation of innovative medicines in Europe, on June 10th, announced the expansion of its longstanding commercial partnership with Alnylam Pharmaceuticals, Inc., one of the leading RNAi therapeutics companies. The extended agreement broadens the geographical reach of the collaboration to include four Nordic markets […]
QIAGEN Showcases AI-Driven Oncology Innovations at AACR 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) recently announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, demonstrating how its portfolio connects sample preparation with multi-omics profiling and genomic data interpretation to support cancer research and molecular diagnostics. “Cancer research and […]
Byondis Appoints Christoph Korpus CEO, Founder Jacques Lemmens Becomes Chairman
Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, recently announced the appointment of Christoph Korpus, PhD, MBA, as Chief Executive Officer (CEO), effective immediately. Christoph has served as Chief Business Officer (CBO) of the Company since January 2025. He succeeds Byondis Founder and former CEO Jacques Lemmens, PhD, who […]
From Chile to the World: How Botanical Solution Inc. is Revolutionising Agri-Biotech
The global agriculture and pharmaceutical industries face a common, critical challenge: securing a stable, scalable, consistent, and sustainable supply of essential natural compounds. As regulatory pressures, environmental concerns, and supply chain vulnerabilities intensify, the need for technological disruption has never been more acute. Answering this call is Botanical Solution Inc. (BSI), a company that began […]
Nippon Express enters into partnership with Pharma.Aero
Nippon Express (Belgium) NV/SA (hereinafter “NX Belgium”), a group company of Nippon Express Holdings inc, became the first Japanese freight forwarder to enter this Year Pharma.Aero. Nippon Express Group has positioned the pharmaceutical industry as a key industry in its “Nippon Express Group Business Plan 2023 Dynamic Growth” and pursues the global development of a […]
Field Medical appoints Mark Wisniewski and Marlou Janssen to its BOD
Field Medical, Inc., a leader in focal pulsed field catheter ablation technology, today announced that Mark Wisniewski, Chief Financial Officer of Enterra Medical Inc. and former Chief Financial Officer of FARAPULSE Inc. was elected to the Board of Directors of Field Medical, alongside medical technology specialist Marlou Janssen, who previously held several senior management positions […]
TSFE and B Investments co-invest in Egypt’s healthcare sector
The Sovereign Fund of Egypt (“TSFE”) through its healthcare and pharmaceutical industries Subfund (“TSFE Healthcare & Pharma Subfund”) and B Investments Holding S.A.E. (“B Investments”), BPE Partners’ flagship investment vehicle, announce the signing of two agreements to invest over EGP 2 billion in specialized healthcare, and pharmaceuticals distribution and trade services in Egypt. The first […]
Accops offers facial authentication solution for DaaS Users
Accops Systems, an India-based global provider of integrated remote access products and solutions, has launched Accops BioAuth, a fingerprint and facial authentication solution with continuous user environment monitoring, enabling organizations to authenticate DaaS users no matter where they are working from. According to Accops systems claims, this is a unique solution aiding in data-sensitive businesses, […]
